Medon Pharmaceuticals Private Limited

Pharmaceutical trading company based in Ranchi, Jharkhand since 2016.

2016 | Ranchi, Jharkhand (India) | Active
Last Updated: October 24, 2024

Medon Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 8 Year, 5 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 2.00 M
  • Revenue Growth -21.63%
  • Profit Growth -59.47%
  • Ebitda 29.48%
  • Net Worth 1.04%
  • Total Assets 37.62%

About Medon Pharmaceuticals

Medon Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 August 2016 (Eight years and five months 5 days old ). Its registered office is in Ranchi, Jharkhand, India.

The Corporate was formerly known as Medon Pharmaceuticlas Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.

The company currently has active open charges totaling ₹2.00 M.

Kaushlendra Kumar, Kamlawati Devi, Srikant Kumar, and Five other members serve as directors at the Company.

Company Details

  • Location

    Ranchi, Jharkhand, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U74999JH2016PTC009109

  • Company No.

    009109

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    26 Aug 2016

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Jharkhand

Industry

Pharma

What products or services does Medon Pharmaceuticals Private Limited offer?

Medon Pharmaceuticals Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antiepileptic Drugs, Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Surgical & ICU Equipments, Nebulizer Machine & Parts, Psychotherapeutic Agents, Common Disease Medicines, Pharmaceutical Capsules, Allopathic Cough Syrup.

Who are the key members and board of directors at Medon Pharmaceuticals?

Board Members (8)

NameDesignationAppointment DateStatus
Srikant Kumar Country flag representing In Director 26-Aug-2016Current
Ankur Awathi Country flag representing In Director 10-Jun-2020Current
Kaushlendra Kumar Country flag representing In Director 26-Aug-2016Current
Kamlawati Devi Country flag representing In Director 26-Aug-2016Current
Riches Kumar Country flag representing In Director 17-Dec-2020Current
Manju Awasthi Country flag representing In Director 10-Jun-2020Current

Financial Performance of Medon Pharmaceuticals.

Medon Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.63% decrease. The company also saw a substantial fall in profitability, with a 59.47% decrease in profit. The company's net worth moved up by a moderate rise of 1.04%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-21.63%
Revenue from Operations
-21.63%
Total Assets
37.62%
Profit or Loss
-59.47%
Net Worth
1.04%
EBITDA
29.48%

What is the Ownership and Shareholding Structure of Medon Pharmaceuticals?

In 2023, Medon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹2.00 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 0.20 Cr

Latest Charge Details

DateLenderAmountStatus
02 May 2017Others₹2.00 MOpen

How Many Employees Work at Medon Pharmaceuticals?

Medon Pharmaceuticals has a workforce of 0 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medon Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Medon Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Medon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Medon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Jharkhand.

    31 Mar 2023

  • Director Appointment

    Riches Kumar was appointed as a Director was appointed as a Director on 17 Dec 2020 & has been associated with this company since 4 years 1 month .

    17 Dec 2020

  • Director Appointment

    Manju Awasthi was appointed as a Director was appointed as a Director on 10 Jun 2020 & has been associated with this company since 4 years 7 months .

    10 Jun 2020

  • Charges

    A charge with Others amounted to Rs. 2.00 M with Charge ID 100101079 was registered on 02 May 2017.

    02 May 2017

  • Director Appointment

    Kaushlendra Kumar was appointed as a Director was appointed as a Director on 26 Aug 2016 & has been associated with this company since 8 years 5 months .

    26 Aug 2016

Frequently asked questions

  • Medon Pharmaceuticals Private Limited was incorporated on 26 Aug 2016.

  • The authorized share capital of Medon Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.

  • Currently 8 directors are associated with Medon Pharmaceuticals Private Limited.

    • Kaushlendra Kumar
    • Kamlawati Devi
    • Srikant Kumar
    • Riches Kumar
    • Manju Awasthi
    • Priyanka Kumari
    • Ankur Awathi
    • Ravi Kumar
  • As per Ministry of Corporate Affairs (Mca), the registered address of Medon Pharmaceuticals Private Limited is H.No. 235 Bhola Chaubey Gali, Chutia India, Ranchi, Jharkhand, 834001.

  • The corporate identification number (CIN) of Medon Pharmaceuticals Private Limited is U74999JH2016PTC009109 and the company number is 009109 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2023, the revenue trend for Medon Pharmaceuticals Private Limited has fallen by -21.63%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Medon Pharmaceuticals Private Limited has experienced an upsurge of 1.04%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Medon Pharmaceuticals Private Limited amount to ₹ 2.00 M.

  • The most recent Balance Sheet for Medon Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.